万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_journal_home_pr?p_JournalId=4
3、投稿网址：
http://mc.manuscriptcentral.com/journals-clarivate
4、期刊刊期：月刊，一年出版12期。
2021年8月19日星期四
投稿须知【官网信息】
Instructions for Authors
Submission of Manuscripts
Manuscripts should be submitted online to the journal's manuscript submission site. Manuscripts published previously in print or electronic format, or submitted for consideration elsewhere, are not acceptable. The journal’s requirements are in accordance with the ICMJE Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals. Manuscripts should be submitted in Word format, typed, double-spaced, preferably using Arial or Times New Roman fonts (font size 10-12), with ample margins and no right justification. Manuscripts should be logically divided into sections and subsections as appropriate and should include a summary (150-200 words) of the objectives, major points and conclusions of the article, text, acknowledgments/disclosures, references and, where appropriate, figures, tables and legends.
Plagiarism is the use of any intellectual content from another author without clear attribution. This includes large amounts of text, images, and ideas as well as rephrasing of other's work or ideas. Re-use of text from an author's previous work without clear citation is self-plagiarism. Manuscripts including clear cases of plagiarism of any kind are not accepted by the journal.
Drug monographs should include the following sections (where applicable):
Summary. A brief summary (no more than 150 words) of the main points addressed.
Background. A brief introduction covering a specific condition, target or class of agents related to the drug/biologic in question.
Preclinical Pharmacology. Summaries of in vitro and in vivo pharmacology studies.
Pharmacokinetics and Metabolism. Summaries of the preclinical and clinical data on the pharmacokinetics/metabolism.
Safety. Summaries of preclinical and clinical studies describing the toxicity and adverse events.
Clinical Studies. Summaries of clinical trials conducted, as well as mention of ongoing clinical trials (ClinicalTrials.gov).
Indications. The main indication for which the drug/biologic has been approved or marketed.
Drug Interactions. Summaries of studies dealing with interactions or potential interactions with other drugs.
Acknowledgments/Disclosures. See below.
References. See below.
Title Page
The title page should contain the full title and the running title of the article, the full names and affiliations of all the authors, as well as the mailing address, telephone, fax and e-mail for the corresponding author. If an author's affiliation has changed since the article was written, the new affiliation should also be listed. A Contents section including all the major section headings in the article should also be included.
Figures
Figures should be numbered in Arabic numerals in the order of their citation in the text. A legend should be included at the bottom of each figure. Figures should be sent as separate PPT, TIF or EPS files (300 dots per inch).
Tables
Tables should be numbered in Roman numerals in the order of their citation in the text. A title should be included at the top of each table and all tables should be included following the reference section.
……
更多详情：
https://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_instauthors_pr?p_JournalID=4
